Leslie R. Laufman, MD

Hematology Oncology Consultants, IncorporatedColumbus, Ohio - 43235 (614-846-0044) Hematology Oncology Consultants, IncColumbus, Ohio - 43235 Hematology Oncology ConsultantsNaperville, Illinois - 60540 (630-369-1501) |
- CLINICAL TRIALS 3
- CONDITIONS4
- INTERVENTIONS5
- SINCE2003

Paclitaxel With or Without Sorafenib in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
June 2007 - June 2014

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
October 2003 -

Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
March 2006 - June 2012
Breast Neoplasms
Neoplasm Metastasis
Bone Neoplasms
Bone Marrow Diseases
Placebo
Paclitaxel
Sorafenib Tosylate
Doxil And Vinorelbine
Zometa® (Zoledronic Acid)



